Preliminary studies indicate conolidine may inhibit distinct ion channels, reducing neuronal excitability and limiting pain alerts. This system is particularly related in neuropathic pain, where irregular signaling leads to persistent irritation. Also, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to agony notion.